Small cell carcinoma of the prostate: implications for management.
Adshead
F
F
Department of Medicine, Royal Marsden Hospital, London.
De Graeff
A
A
Mansi
J L
JL
Thomas
D M
DM
Smith
I E
IE
D000230:Adenocarcinoma / Q000556:secondary; D000616:Aminoglutethimide / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000556:secondary; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D000616:Aminoglutethimide; D004317:Doxorubicin; D003520:Cyclophosphamide